209 related articles for article (PubMed ID: 26518945)
1. Alloreactive T Cells to Identify Risk HLA Alleles for Retransplantation After Acute Accelerated Steroid-Resistant Rejection.
Leyking S; Wolf M; Mihm J; Schaefer M; Bohle RM; Fliser D; Sester M; Sester U
Transplant Proc; 2015 Oct; 47(8):2425-32. PubMed ID: 26518945
[TBL] [Abstract][Full Text] [Related]
2. Donor-specific alloreactive T cells can be quantified from whole blood, and may predict cellular rejection after renal transplantation.
Fischer M; Leyking S; Schäfer M; Elsäßer J; Janssen M; Mihm J; van Bentum K; Fliser D; Sester M; Sester U
Eur J Immunol; 2017 Jul; 47(7):1220-1231. PubMed ID: 28426152
[TBL] [Abstract][Full Text] [Related]
3. KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation.
Littera R; Piredda G; Argiolas D; Lai S; Congeddu E; Ragatzu P; Melis M; Carta E; Michittu MB; Valentini D; Cappai L; Porcella R; Alba F; Serra M; Loi V; Maddi R; Orrù S; La Nasa G; Caocci G; Cusano R; Arras M; Frongia M; Pani A; Carcassi C
PLoS One; 2017; 12(7):e0180831. PubMed ID: 28686681
[TBL] [Abstract][Full Text] [Related]
4. Rapid identification of preformed alloreactive T cells for use in a clinical setting.
Sester U; Thijssen S; van Bentum K; Neumann F; Kubuschok B; Sester M; Köhler H
Transplantation; 2004 Aug; 78(4):607-14. PubMed ID: 15446322
[TBL] [Abstract][Full Text] [Related]
5. Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.
Crespo E; Cravedi P; Martorell J; Luque S; Melilli E; Cruzado JM; Jarque M; Meneghini M; Manonelles A; Donadei C; Lloberas N; Gomà M; Grinyó JM; Heeger P; Bestard O
Kidney Int; 2017 Jul; 92(1):201-213. PubMed ID: 28274484
[TBL] [Abstract][Full Text] [Related]
6. Pre-transplant donor-specific T-cell alloreactivity is strongly associated with early acute cellular rejection in kidney transplant recipients not receiving T-cell depleting induction therapy.
Crespo E; Lucia M; Cruzado JM; Luque S; Melilli E; Manonelles A; Lloberas N; Torras J; Grinyó JM; Bestard O
PLoS One; 2015; 10(2):e0117618. PubMed ID: 25689405
[TBL] [Abstract][Full Text] [Related]
7. Pre-transplant immune state defined by serum markers and alloreactivity predicts acute rejection after living donor kidney transplantation.
Vondran FW; Timrott K; Kollrich S; Steinhoff AK; Kaltenborn A; Schrem H; Klempnauer J; Lehner F; Schwinzer R
Clin Transplant; 2014 Sep; 28(9):968-79. PubMed ID: 24931031
[TBL] [Abstract][Full Text] [Related]
8. Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation.
Meneghini M; Crespo E; Niemann M; Torija A; Lloberas N; Pernin V; Fontova P; Melilli E; Favà A; Montero N; Manonelles A; Cruzado JM; Palou E; Martorell J; Grinyó JM; Bestard O
Front Immunol; 2020; 11():623276. PubMed ID: 33776988
[TBL] [Abstract][Full Text] [Related]
9. The TreaT-Assay: A Novel Urine-Derived Donor Kidney Cell-Based Assay for Prediction of Kidney Transplantation Outcome.
Thieme CJ; Weist BJD; Mueskes A; Roch T; Stervbo U; Rosiewicz K; Wehler P; Stein M; Nickel P; Kurtz A; Lachmann N; Choi M; Schmueck-Henneresse M; Westhoff TH; Reinke P; Babel N
Sci Rep; 2019 Dec; 9(1):19037. PubMed ID: 31836826
[TBL] [Abstract][Full Text] [Related]
10. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody.
Shoker A; Klassen J; Herbut B
Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455
[TBL] [Abstract][Full Text] [Related]
11. Non-HLA T-cell reactivity during the first year after HLA-identical living-related kidney transplantation.
Gerrits JH; van de Wetering J; Drabbels JJ; IJzermans JN; Claas FH; Weimar W; van Besouw NM
Clin Transplant; 2009; 23(5):740-7. PubMed ID: 19563488
[TBL] [Abstract][Full Text] [Related]
12. Sepsis after renal transplantation: Clinical, immunological, and microbiological risk factors.
Schachtner T; Stein M; Reinke P
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28296035
[TBL] [Abstract][Full Text] [Related]
13. Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression.
van der Mast BJ; van Besouw NM; de Kuiper P; Vaessen LM; Gregoor PJ; IJzermans JN; van Gelder T; Claas FH; Weimar W
Transplantation; 2001 Sep; 72(5):873-80. PubMed ID: 11571453
[TBL] [Abstract][Full Text] [Related]
14. A strategy to protect off-the-shelf cell therapy products using virus-specific T-cells engineered to eliminate alloreactive T-cells.
Quach DH; Becerra-Dominguez L; Rouce RH; Rooney CM
J Transl Med; 2019 Jul; 17(1):240. PubMed ID: 31340822
[TBL] [Abstract][Full Text] [Related]
15. Pre-transplant donor-specific Interferon-gamma-producing cells and acute rejection of the kidney allograft.
Slavcev A; Rybakova K; Svobodova E; Slatinska J; Honsova E; Skibova J; Viklicky O; Striz I
Transpl Immunol; 2015 Oct; 33(2):63-8. PubMed ID: 26254561
[TBL] [Abstract][Full Text] [Related]
16. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.
Vo AA; Peng A; Toyoda M; Kahwaji J; Cao K; Lai CH; Reinsmoen NL; Villicana R; Jordan SC
Transplantation; 2010 May; 89(9):1095-102. PubMed ID: 20110854
[TBL] [Abstract][Full Text] [Related]
17. Next generation sequencing based assessment of the alloreactive T cell receptor repertoire in kidney transplant patients during rejection: a prospective cohort study.
Aschauer C; Jelencsics K; Hu K; Heinzel A; Vetter J; Fraunhofer T; Schaller S; Winkler S; Pimenov L; Gualdoni GA; Eder M; Kainz A; Regele H; Reindl-Schwaighofer R; Oberbauer R
BMC Nephrol; 2019 Sep; 20(1):346. PubMed ID: 31477052
[TBL] [Abstract][Full Text] [Related]
18. Alloreactivity in renal transplant recipients with and without chronic allograft nephropathy.
Poggio ED; Clemente M; Riley J; Roddy M; Greenspan NS; Dejelo C; Najafian N; Sayegh MH; Hricik DE; Heeger PS
J Am Soc Nephrol; 2004 Jul; 15(7):1952-60. PubMed ID: 15213286
[TBL] [Abstract][Full Text] [Related]
19. Donor-reactive cytokine profiles after HLA-identical living-related kidney transplantation.
Gerrits JH; van de Wetering J; Drabbels JJ; Claas FH; Weimar W; van Besouw NM
Nephrol Dial Transplant; 2008 Jun; 23(6):2016-23. PubMed ID: 18156655
[TBL] [Abstract][Full Text] [Related]
20. Donor-specific hypo-responsiveness occurs in simultaneous liver-kidney transplant recipients after the first year.
Taner T; Gustafson MP; Hansen MJ; Park WD; Bornschlegl S; Dietz AB; Stegall MD
Kidney Int; 2018 Jun; 93(6):1465-1474. PubMed ID: 29656904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
